NO20091771L - Ny krystall av (S)-(+)-2-(2-klorfenyl)-2-hydroksyetylkarbamat - Google Patents
Ny krystall av (S)-(+)-2-(2-klorfenyl)-2-hydroksyetylkarbamatInfo
- Publication number
- NO20091771L NO20091771L NO20091771A NO20091771A NO20091771L NO 20091771 L NO20091771 L NO 20091771L NO 20091771 A NO20091771 A NO 20091771A NO 20091771 A NO20091771 A NO 20091771A NO 20091771 L NO20091771 L NO 20091771L
- Authority
- NO
- Norway
- Prior art keywords
- hydroxyethylcarbamate
- chlorophenyl
- crystal
- fresh crystal
- fresh
- Prior art date
Links
- 239000013078 crystal Substances 0.000 title abstract 4
- LBHQHDWMTSQPKV-MRVPVSSYSA-N [(2s)-2-(2-chlorophenyl)-2-hydroxyethyl]carbamic acid Chemical compound OC(=O)NC[C@@H](O)C1=CC=CC=C1Cl LBHQHDWMTSQPKV-MRVPVSSYSA-N 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/12—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Liquid Crystal Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82839206P | 2006-10-06 | 2006-10-06 | |
| PCT/US2007/021502 WO2008045391A2 (en) | 2006-10-06 | 2007-10-05 | Novel crystal of (s)-(+)-2-(2-chlorophenyl)-2-hydroxy-ethyl carbamate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20091771L true NO20091771L (no) | 2009-05-05 |
Family
ID=39283405
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20091771A NO20091771L (no) | 2006-10-06 | 2009-05-05 | Ny krystall av (S)-(+)-2-(2-klorfenyl)-2-hydroksyetylkarbamat |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7632963B2 (pt) |
| EP (1) | EP2076258A4 (pt) |
| JP (1) | JP2010505856A (pt) |
| KR (1) | KR20090076958A (pt) |
| CN (1) | CN101657195A (pt) |
| AU (1) | AU2007307029A1 (pt) |
| BR (1) | BRPI0718131A2 (pt) |
| CA (1) | CA2665573A1 (pt) |
| CO (1) | CO6180504A2 (pt) |
| CR (1) | CR10764A (pt) |
| EA (1) | EA200970355A1 (pt) |
| GT (1) | GT200900076A (pt) |
| IL (1) | IL198016A0 (pt) |
| MX (1) | MX2009003755A (pt) |
| NI (1) | NI200900050A (pt) |
| NO (1) | NO20091771L (pt) |
| SV (1) | SV2009003211A (pt) |
| WO (1) | WO2008045391A2 (pt) |
| ZA (1) | ZA200903095B (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8609849B1 (en) | 2010-11-30 | 2013-12-17 | Fox Chase Chemical Diversity Center, Inc. | Hydroxylated sulfamides exhibiting neuroprotective action and their method of use |
| EP2797880B1 (en) * | 2011-12-27 | 2017-03-01 | Bio-Pharm Solutions Co., Ltd. | Phenyl carbamate compounds for use in preventing or treating epilepsy |
| KR102399807B1 (ko) * | 2021-08-05 | 2022-05-20 | (주)바이오팜솔루션즈 | 페닐카바메이트 결정형 및 이의 제조 방법 |
| WO2023014160A1 (ko) * | 2021-08-05 | 2023-02-09 | (주)바이오팜솔루션즈 | 페닐카바메이트 결정형 및 이의 제조 방법 |
| US12054449B2 (en) | 2021-08-05 | 2024-08-06 | Bio-Pharm Solutions Co., Ltd. | Phenylcarbamate crystalline form and method for manufacturing the same |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5698588A (en) * | 1996-01-16 | 1997-12-16 | Yukong Limited | Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol |
| CA2349663C (en) * | 1999-09-10 | 2006-10-31 | Dainippon Ink And Chemicals, Inc. | Quinolinone derivative formulation and its production method |
| PL364680A1 (en) * | 2001-02-27 | 2004-12-13 | Ortho-Mcneil Pharmaceutical, Inc. | Carbamate compounds for use in preventing or treating neurodegenerative disorders |
| HRP20040557A2 (en) * | 2001-12-21 | 2005-04-30 | Ortho-Mcneil Pharmaceutical | Process for preparing 2-(substituted phenyl)-2-hydroxy carbamates |
| PL1658277T3 (pl) * | 2003-08-18 | 2012-10-31 | H Lundbeck As | Sól bursztynianowa i malonianowa trans-4-((1R,3S)-6-chloro-3-fenyloindan-1-ylo)-1,2,2-tri-metylopiperazyny i zastosowanie jako lek |
| CA2580640A1 (en) * | 2004-09-16 | 2006-03-30 | Janssen Pharmaceutica N.V. | Methods of treating epileptogensis and epilepsy |
| US20070021500A1 (en) * | 2005-07-12 | 2007-01-25 | Twyman Roy E | Methods for neuroprotection |
-
2007
- 2007-10-05 CN CN200780045483A patent/CN101657195A/zh active Pending
- 2007-10-05 US US11/867,803 patent/US7632963B2/en not_active Expired - Fee Related
- 2007-10-05 EA EA200970355A patent/EA200970355A1/ru unknown
- 2007-10-05 AU AU2007307029A patent/AU2007307029A1/en not_active Abandoned
- 2007-10-05 WO PCT/US2007/021502 patent/WO2008045391A2/en not_active Ceased
- 2007-10-05 MX MX2009003755A patent/MX2009003755A/es active IP Right Grant
- 2007-10-05 CA CA002665573A patent/CA2665573A1/en not_active Abandoned
- 2007-10-05 BR BRPI0718131-0A2A patent/BRPI0718131A2/pt not_active IP Right Cessation
- 2007-10-05 EP EP07839353A patent/EP2076258A4/en not_active Withdrawn
- 2007-10-05 KR KR1020097009191A patent/KR20090076958A/ko not_active Withdrawn
- 2007-10-05 JP JP2009531487A patent/JP2010505856A/ja not_active Withdrawn
-
2009
- 2009-04-03 SV SV2009003211A patent/SV2009003211A/es not_active Application Discontinuation
- 2009-04-03 NI NI200900050A patent/NI200900050A/es unknown
- 2009-04-05 IL IL198016A patent/IL198016A0/en unknown
- 2009-04-06 GT GT200900076A patent/GT200900076A/es unknown
- 2009-04-07 CO CO09035814A patent/CO6180504A2/es not_active Application Discontinuation
- 2009-05-05 ZA ZA200903095A patent/ZA200903095B/xx unknown
- 2009-05-05 CR CR10764A patent/CR10764A/es not_active Application Discontinuation
- 2009-05-05 NO NO20091771A patent/NO20091771L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0718131A2 (pt) | 2013-11-05 |
| CN101657195A (zh) | 2010-02-24 |
| AU2007307029A1 (en) | 2008-04-17 |
| CR10764A (es) | 2009-09-14 |
| KR20090076958A (ko) | 2009-07-13 |
| ZA200903095B (en) | 2010-07-28 |
| IL198016A0 (en) | 2009-12-24 |
| SV2009003211A (es) | 2009-11-24 |
| CA2665573A1 (en) | 2008-04-17 |
| GT200900076A (es) | 2010-05-18 |
| JP2010505856A (ja) | 2010-02-25 |
| EA200970355A1 (ru) | 2009-12-30 |
| US7632963B2 (en) | 2009-12-15 |
| WO2008045391A3 (en) | 2008-06-12 |
| EP2076258A4 (en) | 2011-09-28 |
| NI200900050A (es) | 2010-02-01 |
| WO2008045391A2 (en) | 2008-04-17 |
| CO6180504A2 (es) | 2010-07-19 |
| MX2009003755A (es) | 2009-07-10 |
| US20080085930A1 (en) | 2008-04-10 |
| EP2076258A2 (en) | 2009-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201000642A1 (ru) | 2'-фтор-2'-дезокситетрагидроуридины в качестве ингибиторов цитидиндеаминазы | |
| EA201070786A1 (ru) | Бензофуропиримидиноны | |
| NO20084652L (no) | Deazapuriner anvendelige som inhibitorer av januskinaser | |
| EA200970581A1 (ru) | Кристаллическое твёрдое основание разагилина | |
| TN2010000060A1 (en) | Proteasome inhibitors | |
| NO20092637L (no) | Fremgangsmater for behandling | |
| NO20083002L (no) | Fremgangsmate for anvendelse av CD40-bindende forbindelser | |
| EA201200669A1 (ru) | ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα | |
| EA201170508A1 (ru) | Производные 1-амино-2-циклобутилэтилбороновой кислоты | |
| CY1112653T1 (el) | Κρυσταλλικες τροποποιησεις της πυρακλοστροβινης | |
| EA200970156A1 (ru) | Пиридизиноновые производные | |
| EA200800760A1 (ru) | ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα | |
| EA200870193A1 (ru) | Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение | |
| EA201290183A1 (ru) | Бензодиазепиновый ингибитор бромодомена | |
| NO20090157L (no) | Tienpyrimidiner anvendelige som modulatorer av ionekanaler | |
| NO20090596L (no) | Antivirale fosfinatforbindelser | |
| NO20080141L (no) | Indanderivater som modulatorer av ionekanaler | |
| EA201401193A1 (ru) | Триарильные соединения и композиции, их содержащие | |
| EA201170703A1 (ru) | Производные адамантилбензамида | |
| EA200700096A1 (ru) | Производные 2-карбамид-4-фенилтиазола, способ их получения и их применение в терапии | |
| EA201070424A1 (ru) | Хиназолиндионовые производные, их получение и их применения в терапии | |
| EA201070009A1 (ru) | Производные 7-алкинил-1,8-нафтиридонов, их получение и их применение в терапии | |
| WO2008061108A3 (en) | Phthalazine derivatives | |
| EA201000814A1 (ru) | 5-[(3,3,3-трифтор-2-гидрокси-1-арилпропил)амино]-1h-хинолин-2-оны, способ их получения и их применение в качестве противовоспалительных средств | |
| TW200621721A (en) | Methods of preparing indazole compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |